mainly in order to accommodate the ever-increasing
Introduction
between the two units.
All patients in Tassin and Nottingham who had commenced haemodialysis (as the initial mode of renal replaceIn the 1970s, almost all dialysis facilities reduced ment therapy (RRT )) since 1980 were included in this haemodialysis session time to 5 h thrice weekly or less, retrospective study. This starting year (1980) was chosen because by then all patients dialysing in Nottingham were A. Innes et al. 920 being unchanged since the 1960s. Since 1980, procedures for Tassin, 48% of the patients were smokers; the figure vascular access and the management of anaemia have for Nottingham was 44%.
changed throughout the dialysis community. Actuarial surActuarial survival for all patients is shown in 
Results
shown in Table 1 . Patients with standard and nonstandard renal diseases were compared between the two centres. These are defined using the criteria In Tassin, 452 patients were studied; in Nottingham, described by the EDTA registry [6 ] . Standard diseases 282. The median (range) age of patients at the start of include glomerulonephritis, reflux nephropathy and dialysis was 54 (13-91) years in Tassin and 56 polycystic kidney disease; the latter group includes years in Nottingham. The male5female ratio was 1.851 diabetic nephropathy, hypertensive nephrosclerosis in Tassin and 1.9851 in Nottingham. The proportion and systemic diseases. We also compared diabetics and of patients who were diabetic in each centre was similar: 12.2% in Tassin; 11.7% in Nottingham. In non-diabetics and those with and without cardiovas- European registry data but also the presence of cardiovascular disease prior to dialysis (the main cause of Any age with visceral or haematological malignancy death in dialysis patients) [3] . We also used the same method to assess comorbidity as the group comparing two Scottish centres [7, 8] . Our analysis of subgroups cular antecedents. Cardiovascular antecedents were excluded patients who died or received treatment for defined as evidence of vascular disease (ischaemic heart less than 90 days. Although we have previously disease, myocardial infarction, stroke, transient ischemphasized the importance of this group [14] , it is aemic attack or peripheral vascular disease) prior to difficult to compare the effects of two haemodialysis starting dialysis. Further comparison was made techniques in the short term in such a heterogeneous between patients at both centres using a risk stratificagroup (including many patients who have required tion based on age and comorbid conditions as dialysis as an emergency). Their exclusion has been described by Wright [7, 8] . A summary of the inclusion suggested to provide more accurate comparison criteria is shown in The benefits on improved survival on long, slow with standard renal disease, for non-diabetics (both haemodialysis are found in patients with standard P<0.001) and for those with (P=0.007) and without renal diseases, non-diabetics, and those in the low-and (P<0.001) cardiovascular antecedents. Survival in medium-risk stratification groups. Enhanced survival Tassin was also better for low-risk and medium-risk was also noted in the Tassin patients both with and groups (both P<0.001) using risk stratification.
without cardiovascular antecedents. Diabetics, those Survival did not differ significantly between the two in the high-risk group, and patients with non-standard centres for patients with non-standard renal diseases, renal diseases did not have significantly improved diabetics, and those in the high-risk group ( Table 1) .
survival. The relative risk of age, risk stratification, renal
The results suggest that in general those in the most disease, cardiovascular antecedents, and dialysis centre favourable categories in each subgroup analysis do are shown in Table 3 . better in Tassin, whereas those with the worst outlook did not have improved survival. Diabetic patients
Discussion
showed no significant difference in survival, with a uniformly gloomy prognosis in both Nottingham and Tassin though the numbers in each group were small. Survival is the ultimate measure for dialysis adequacy [1] . Published studies and registry data observing The high-risk stratification group also had no survival 
